For example, two groups have reported that midbrain dopaminergic neurons (mDANs) differentiated from iPSCs generated from patients with Parkinson’s disease (PD) with mutations in the gene LRRK2 exhibit disease-associated phenotypes [2], [3]. This evidence concerns the gene LRRK2 and Parkinson disease.